Tag: INSOMNIA

New Study: Insomnia’s Impact Comes From Unpredictability, Not Sleep Duration
Artificial Intelligence in Sleep Medicine Insomnia

New Study: Insomnia’s Impact Comes From Unpredictability, Not Sleep Duration

 Sleep.ai announced findings from a peer-reviewed study led by Washington State University, in collaboration with the University of Washington, exploring sleep patterns in people with chronic insomnia. It is the longest known objective, real-world characterization of objective sleep in chronic insomnia. Published in JMIR Formative Research, the study tracked 112 adults […]

Nexalin Announces Peer-Reviewed Publication with Neuroimagina Data in Psychotherapy and Psychosomatics Hiahliahting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
Clinical Studies & Findings Insomnia

Nexalin Study Shows Brain-Network Changes and Sleep Improvement in Chronic Insomnia

Nexalin Technology, Inc. announced the online publication of a peer-reviewed study in Psychotherapy and Psychosomatics reporting significant clinical improvement and measurable brain-network modulation in patients with chronic insomnia treated with the Company’s high-power 15 mA, 77.5 Hz stimulation approach. The paper was published online on 四月 20, 2026.  The study, titled: “Modulating […]

Nexalin 宣布啟動關鍵性 HALO Clarity 臨床試驗,以支持其針對價值數十億美元失眠市場所規劃的 FDA「De Novo」申請
Industry News & Updates Insomnia Research & Studies

Nexalin 的 HALO Clarity 臨床試驗將為針對失眠市場所規劃的 FDA De Novo 申請提供支持

Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]

quviviq Daridorexant dual orexin receptor antagonist
Sleep Pharmaceuticals Product & Vendor Updates

QUVIVIQ Wins Best Biotechnology & Pharmaceutical Product

Idorsia Ltd announces that its novel treatment for insomnia disorder QUVIVIQ (Daridorexant) has been awarded the inaugural Prix Galien Bridges Award in the category of “Best Biotechnology & Pharmaceutical Product”. The award recognizes groundbreaking medicines, including biologics, gene therapies, and traditional pharmaceutical compounds, that advance patient care through scientific innovation. […]

NOCTEM Health
《SleepWorld》雜誌 研究與調查

NOCTEM Health

據估計,全球每三名成年人中就有一人出現失眠症狀,然而其中僅有極少數患者能接觸到受過「失眠認知行為療法(CBTI)」專業訓練的專家——該療法被視為治療的黃金標準。1,2 這項未被滿足的需求已在行為睡眠醫學領域形成重大瓶頸,該領域的需求遠遠超過[…]